Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
Solventum
SOLV
$15B
| $118M | 0.01% |
1,533,215
-229,792
| -13% | -$16.8M |
2024 Q1
9 quarters
|
|
1427
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.71B
| $118M | 0.01% |
4,643,495
+1,925,547
| +71% | +$48.4M |
2013 Q2
52 quarters
|
|
1428
Silicon Laboratories
SLAB
$7.38B
| $118M | 0.01% |
540,037
-50,871
| -9% | -$11M |
2013 Q2
52 quarters
|
|
1429
Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF
QDPL
$1.84B
| $118M | 0.01% |
2,618,686
+84,587
| +3% | +$3.75M |
2024 Q1
9 quarters
|
|
1430
American Financial Group
AFG
$12.1B
| $118M | 0.01% |
843,366
-59,146
| -7% | -$7.84M |
2013 Q2
52 quarters
|
|
1431
Goldman Sachs Access Ultra Short Bond ETF
GSST
$1.66B
| $118M | 0.01% |
2,332,813
+361,054
| +18% | +$18.2M |
2020 Q4
22 quarters
|
|
1432
APi Group
APG
$17.4B
| $118M | 0.01% |
2,782,919
-423,932
| -13% | -$18.5M |
2020 Q2
24 quarters
|
|
1433
Casella Waste Systems
CWST
$5.5B
| $118M | 0.01% |
1,213,469
+18,175
| +2% | +$1.55M |
2013 Q2
52 quarters
|
|
1434
Frontdoor
FTDR
$5.39B
| $118M | 0.01% |
1,515,164
-93,603
| -6% | -$5.99M |
2018 Q4
30 quarters
|
|
1435
Neuberger Next Generation Connectivity Fund Inc
NBXG
$1.2B
| $117M | 0.01% |
7,070,195
-435,108
| -6% | -$6.65M |
2021 Q2
20 quarters
|
|
1436
Descartes Systems
DSGX
$7.58B
| $117M | 0.01% |
1,687,878
+199,249
| +13% | +$14.2M |
2013 Q4
50 quarters
|
|
1437
Arcutis Biotherapeutics
ARQT
$3.66B
| $117M | 0.01% |
4,451,014
+232,083
| +6% | +$5.41M |
2020 Q1
25 quarters
|
|
1438
Fidelity MSCI Information Technology Index ETF
FTEC
$21.5B
| $116M | 0.01% |
407,348
+4,854
| +1% | +$1.27M |
2014 Q1
49 quarters
|
|
1439
Commerce Bancshares
CBSH
$7.97B
| $116M | 0.01% |
2,012,537
-280,265
| -12% | -$14.7M |
2013 Q2
52 quarters
|
|
1440
Avantis Core Fixed Income ETF
AVIG
$2B
| $116M | 0.01% |
2,802,723
+505,918
| +22% | +$21M |
2024 Q4
6 quarters
|
|
1441
Encompass Health
EHC
$12.6B
| $116M | 0.01% |
1,146,873
+249,891
| +28% | +$25.9M |
2013 Q2
52 quarters
|
|
1442
WisdomTree US Total Dividend Fund
DTD
$1.66B
| $116M | 0.01% |
1,240,413
+24,017
| +2% | +$2.19M |
2013 Q2
52 quarters
|
|
1443
StoneX
SNEX
$7.23B
| $116M | 0.01% |
1,463,598
+40,843
| +3% | +$3.06M |
2013 Q4
50 quarters
|
|
1444
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.03B
| $116M | 0.01% |
9,842,925
-66,345
| -0.7% | -$762K |
2013 Q2
52 quarters
|
|
1445
Nurix Therapeutics
NRIX
$2.73B
| $116M | 0.01% |
4,762,484
-169,515
| -3% | -$2.89M |
2020 Q3
23 quarters
|
|
1446
Agree Realty
ADC
$8.28B
| $116M | 0.01% |
1,525,277
+206,242
| +16% | +$15.6M |
2013 Q2
52 quarters
|
|
1447
Ryman Hospitality Properties
RHP
$8.65B
| $115M | 0.01% |
895,970
+3,086
| +0.3% | +$342K |
2013 Q2
52 quarters
|
|
1448
CarMax
KMX
$7.47B
| $115M | 0.01% |
2,176,424
-358,315
| -14% | -$15.6M |
2013 Q2
52 quarters
|
|
1449
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $115M | 0.01% |
2,130,186
+6,885
| +0.3% | +$358K |
2013 Q2
52 quarters
|
|
1450
Figure Technology Solutions
FIGR
$6.21B
| $115M | 0.01% |
3,747,081
+1,012,158
| +37% | +$33.8M |
2025 Q3
3 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.